Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study

Journal article

Robert P Whitehead, Kenneth J Kopecky, Michael K Samson, John J Constanzi, Ronald B Natale, Lynn G Feun, Evan M Hersh and John J Rinehart

JNCI : Journal of the National Cancer Institute, Vol.83(17), pp.1250-1252

1991-09-04

PMID: 1870152

Metrics

4 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.6 Immunology; 1.6.358 Dendritic Cells
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study
Creators: Robert P Whitehead
Kenneth J Kopecky
Michael K Samson
John J Constanzi
Ronald B Natale
Lynn G Feun
Evan M Hersh
John J Rinehart
Publication Details: JNCI : Journal of the National Cancer Institute, Vol.83(17), pp.1250-1252
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 1870152
Record Identifier: 991031575469202976